Find a Tender
complete
Official procurement procedure
NP47825 Multiple Sclerosis Medicines
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP47825 Multiple Sclerosis Medicines". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
Not availableNo published reports
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published2 May 2025, 09:05 BST | Last source update2 May 2025, 09:05 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-04ce06 | ||
What is being bought
Supply of multiple sclerosis medicines to NHS Scotland.
What changed
From the official release history
- Status changed to complete
2 May 2025, 09:05 BST - Official notice release published
2 May 2025, 09:05 BST - tender value changed
8 Jan 2025, 09:37 GMT - Status changed to published status
8 Jan 2025, 09:37 GMT - Official notice release published
8 Jan 2025, 09:37 GMT - Submission deadline changed to published date
8 Jan 2025, 09:37 GMT - Published value updated to £51,517,832
7 Jan 2025, 17:01 GMT - Status changed to active
7 Jan 2025, 17:01 GMT - Official notice release published
7 Jan 2025, 17:01 GMT - Submission deadline changed to 7 Feb 2025, 12:00 GMT
7 Jan 2025, 17:01 GMT - Buyer information updated
7 Jan 2025, 17:01 GMT
Lots and requirements (2)
Published by the contracting authority
- Lot 1 · #1Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumabcancelledPublished valueNot publishedSupply of glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsulescancelledPublished valueNot publishedSupply of fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules to NHS Scotland. The Authority has award this Lot as a single supplier Framework Agreement per product line to three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
2 May 2025, 09:05 BST - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 15 Apr 2025, 00:00 BST · £602,376 - Contract active
Signed 9 Apr 2025, 00:00 BST · £47,968,904
Commercial outcome and competition
Awards Biogen Idec Ltd, Merck Serono Limited, Orifarm UK, Sandoz Ltd, Teva UK Ltd, Viatris UK Healthcare Ltd Not published · Not published · active Ranbaxy (UK) Ltd, STADA UK - Thornton & Ross, Teva UK Ltd Not published · Not published · active |
Contracts Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules £602,376 · signed 15 Apr 2025, 00:00 BST · active Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab £47,968,904 · signed 9 Apr 2025, 00:00 BST · active |
Bid statistics bids: 6 (lot 1) electronicBids: 6 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 6 (lot 1) smeBids: 0 (lot 1) bids: 10 (lot 2) electronicBids: 10 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 10 (lot 2) smeBids: 0 (lot 2) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contracting authority GB-FTS-115937Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published